Drug Utilization Study of ZALTRAP® (aflibercept) Using European Databases (Zaltrap Utilization Study)

ENCePP Code of conduct

No

Data sources

• Data source(s):
  HTI – Hospital Treatment Insights
• Data source(s), other:
  IMS Oncology Analyzer, United Kingdom
• Data sources (types):
  Other
• Data sources (types), other:
  The IMS Oncology Analyzer™ (OA) is a quarterly structured survey of treated prevalence for over 25 leading solid tumors and hematological malignancies.

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  Unknown